Jeremy Grantham's position in United Therapeutics is currently worth $2.48 Million. That's 0.01% of their equity portfolio (342nd largest holding). The first United Therapeutics trade was made in Q1 2017. Since then Jeremy Grantham bought shares eight more times and sold shares on eight occasions. The stake costed the investor $2.21 Million, netting the investor a gain of 12% so far.